uMed (Pharmaceuticals and Biotechnology) Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
uMed (Pharmaceuticals and Biotechnology) General Information
Description
Developer of a medical research technology platform designed to provide access to healthcare research and delivery. The company's platform automates the clinical study process, creating patient registries that meet regulatory compliance and combine electronic health data with data captured from each patient that can include genomic and biomarker samples, enabling healthcare providers to participate in multiple research programs simultaneously, without increasing overhead or burdens on clinical teams.
Contact Information
Website
www.umed.ioCorporate Office
- 8 Warner Yard
- London EC1R 5EY
- England, United Kingdom
Corporate Office
- 8 Warner Yard
- London EC1R 5EY
- England, United Kingdom
uMed (Pharmaceuticals and Biotechnology) Timeline
uMed (Pharmaceuticals and Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 05-Jul-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 30-Nov-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 13-Jun-2019 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 04-Dec-2018 | $199K | $199K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
uMed (Pharmaceuticals and Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A2 Preferebce | ||||||||
| A Preference | ||||||||
| A Preference | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 52,528 | $0.000127 | $0.6 | $0.6 | 1x | $0.6 | 0.35% | |
| Ordinary | 203,804 | $0.000127 | $0.62 | $0.62 | 1x | $0.62 | 1.38% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
uMed (Pharmaceuticals and Biotechnology) Comparisons
Industry
Financing
Details
uMed (Pharmaceuticals and Biotechnology) Competitors (4)
One of uMed (Pharmaceuticals and Biotechnology)’s 4 competitors is ArisGlobal, a Formerly PE-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ArisGlobal | Formerly PE-Backed | Waltham, MA | ||||
| Medidata Solutions | Formerly VC-backed | New York, NY | ||||
| PicnicAI | Venture Capital-Backed | San Francisco, CA | ||||
| OM1 | Venture Capital-Backed | Boston, MA |
uMed (Pharmaceuticals and Biotechnology) Signals
uMed (Pharmaceuticals and Biotechnology) Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Healthtech Hub | Accelerator/Incubator | |||
| PharmStars | Accelerator/Incubator | |||
| 11.2 Capital | Venture Capital | Minority | ||
| Albion Crown VCT | Venture Capital | Minority | ||
| AlbionVC | Venture Capital | Minority |
uMed (Pharmaceuticals and Biotechnology) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cohort Science | London, United Kingdom | 2021 |
uMed (Pharmaceuticals and Biotechnology) FAQs
-
When was uMed (Pharmaceuticals and Biotechnology) founded?
uMed (Pharmaceuticals and Biotechnology) was founded in 2017.
-
Where is uMed (Pharmaceuticals and Biotechnology) headquartered?
uMed (Pharmaceuticals and Biotechnology) is headquartered in London, United Kingdom.
-
What is the size of uMed (Pharmaceuticals and Biotechnology)?
uMed (Pharmaceuticals and Biotechnology) has 35 total employees.
-
What industry is uMed (Pharmaceuticals and Biotechnology) in?
uMed (Pharmaceuticals and Biotechnology)’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is uMed (Pharmaceuticals and Biotechnology) a private or public company?
uMed (Pharmaceuticals and Biotechnology) is a Private company.
-
What is uMed (Pharmaceuticals and Biotechnology)’s current revenue?
The current revenue for uMed (Pharmaceuticals and Biotechnology) is .
-
How much funding has uMed (Pharmaceuticals and Biotechnology) raised over time?
uMed (Pharmaceuticals and Biotechnology) has raised $18.1M.
-
Who are uMed (Pharmaceuticals and Biotechnology)’s investors?
Healthtech Hub, PharmStars, 11.2 Capital, Albion Crown VCT, and AlbionVC are 5 of 9 investors who have invested in uMed (Pharmaceuticals and Biotechnology).
-
Who are uMed (Pharmaceuticals and Biotechnology)’s competitors?
ArisGlobal, Medidata Solutions, PicnicAI, and OM1 are competitors of uMed (Pharmaceuticals and Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process